Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
MSL Burnout...The Struggle is Real
Summary
In this episode, Jennifer Mohawk joins to discuss the prevalent issue of burnout among Medical Science Liaisons. She shares her insights on the common stressors, including overachievement and post-COVID challenges, that contribute to burnout in the MSL field. Jennifer addresses the impact of travel stress and the pressure of metrics, emphasizing the importance of recognizing early warning signs. She provides effective strategies for managing stress, such as midday movement and aligning personal and organizational values. The episode concludes with Jennifer's advice on building supportive, diverse teams and her final words of wisdom for MSLs.
My guest this week is Jennifer Mohawk, Senior Director, Medical Affairs with Apogee Therapeutics who discusses MSL burnout and how to handle the stress of the job.
Jen shares….
π What is MSL Burnout?
π How to pick up the warning signs
π What Managers can do to help with burnout
π What are ways to minimize and cope with the stress of the job
π What habits should be adopted for MSL sanity
MSL burnout, stress management, Medical Science Liaisons, post-COVID challenges, supportive teams
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
How to Start Presenting Like a Pro
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts KΓ₯gedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Karen Geary